MAJOR UPDATE: Do Not Use Molnupiravur, Favipiravir, Azithromycin, Doxycycline, Ivermectin etc in COVID-19, says ICMR New Guideline Kajal Rajput20 March 2023 12:01 PM IST"Antibiotics should not be used unless there is clinical suspicion of bacterial infection. The possibility of coinfection of COVID-19 with other...
Lopinavir-ritonavir not effective option for patients hospitalized with COVID-19: Lancet Dr. Kamal Kant Kohli6 Oct 2020 5:15 PM ISTThe drug combination lopinavir-ritonavir is not an effective treatment for patients admitted to hospital with COVID-19, according to the results of a...
No Benefits: WHO discontinues hydroxychloroquine, lopinavir/ritonavir trial for Covid-19 treatment MD Bureau5 July 2020 3:45 PM ISTGeneva: The World Health Organization (WHO) announced on Saturday that it was discontinuing hydroxychloroquine and lopinavir/ritonavir arms for its...
No clinical benefit of lopinavir-ritonavir in hospitalised COVID-19 patients: RECOVERY TRIAL Dr. Kamal Kant Kohli30 Jun 2020 7:08 PM ISTStatement from the Chief Investigators of the Randomised Evaluation of COVid-19 thERapY (RECOVERY) Trial on lopinavir-ritonavir, 29 June 2020In March...
Triple antiviral drug combo shows promise in COVID-19 treatment: Lancet Dr. Kamal Kant Kohli9 May 2020 6:00 AM ISTResearchers had first evidence from randomised trial conducted in six public hospitals in Hong Kong regarding new tripleantiviral drug combination for...
